{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:42:41Z","timestamp":1773837761242,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.nmd.2010.06.011","type":"journal-article","created":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T19:36:10Z","timestamp":1278876970000},"page":"548-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Investigating glycogenosis type III patients with multi-parametric functional NMR imaging and spectroscopy"],"prefix":"10.1016","volume":"20","author":[{"given":"Claire","family":"Wary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Nadaj-Pakleza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lafor\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristl G.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Servanne","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Baligand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Eymard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Labrune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre G.","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2010.06.011_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-3476(53)80420-8","article-title":"Glycogen storage disease; report of a case with abnormal glycogen structure in liver and skeletal muscle","volume":"42","author":"Forbes","year":"1953","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2010.06.011_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0021-9258(18)65877-6","article-title":"Amylo-1,6-glucosidase in muscle tissue in generalized glycogen storage disease","volume":"218","author":"Illingworth","year":"1956","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2010.06.011_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-116-11-896","article-title":"Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy","volume":"116","author":"Coleman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0960-8966(99)00038-3","article-title":"Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis","volume":"9","author":"Kiechl","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2010.06.011_bib5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ajmg.1320420514","article-title":"Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis","volume":"42","author":"Momoi","year":"1992","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.nmd.2010.06.011_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1172\/JCI118799","article-title":"Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle","volume":"98","author":"Shen","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2010.06.011_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/humu.9426","article-title":"Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL","volume":"27","author":"Lucchiari","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2010.06.011_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/mgme.1999.2953","article-title":"Genotype\u2013phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease","volume":"69","author":"Shaiu","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2010.06.011_bib9","series-title":"Disorders of Voluntary Muscle","first-page":"1771","article-title":"Clinical examination, differential diagnosis and classification","author":"Walton","year":"1994"},{"key":"10.1016\/j.nmd.2010.06.011_bib10","first-page":"150","article-title":"Improved methodology for dynamic studies of muscle oxygen metabolism using 1H\/31P imaging\/spectroscopy protocols (Abstract)","volume":"9","author":"Raynaud","year":"1999","journal-title":"MAGMA"},{"key":"10.1016\/j.nmd.2010.06.011_bib11","first-page":"153","article-title":"T1-weighted interleaved acquisitions of glycogen and creatine spectra for improved clinical characterisation of glycogenoses by 13C NMR spectroscopy","volume":"11","author":"Wary","year":"2000","journal-title":"MAGMA"},{"key":"10.1016\/j.nmd.2010.06.011_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0960-8966(91)90056-X","article-title":"Diagnosis of muscular glycogenosis by in vivo natural abundance 13C NMR spectroscopy","volume":"1","author":"Jehenson","year":"1991","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2010.06.011_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0960-8966(03)00069-5","article-title":"Evaluation of muscle glycogen content by 13C NMR spectroscopy in adult-onset acid maltase deficiency","volume":"13","author":"Wary","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2010.06.011_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmri.20804","article-title":"Muscle MRI in inherited neuromuscular disorders: past, present, and future","volume":"25","author":"Mercuri","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.nmd.2010.06.011_bib15","first-page":"77","article-title":"Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study","volume":"1","author":"Taylor","year":"1983","journal-title":"Mol Biol Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib16","first-page":"56","article-title":"Exploration of exercise intolerance by 31P NMR spectroscopy of calf muscles coupled with MRI and ergometry","volume":"159","author":"Laforet","year":"2003","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nmd.2010.06.011_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/nbm.1940060404","article-title":"In vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise","volume":"6","author":"Iotti","year":"1993","journal-title":"NMR Biomed"},{"key":"10.1016\/j.nmd.2010.06.011_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/mrm.1192","article-title":"Determination of skeletal muscle perfusion using arterial spin labeling NMRI: validation by comparison with venous occlusion plethysmography","volume":"46","author":"Raynaud","year":"2001","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib19","first-page":"751","article-title":"An interleaved heteronuclear NMRI\u2013NMRS approach to non-invasive investigation of exercising human skeletal muscle","volume":"43","author":"Brillault-Salvat","year":"1997","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.nmd.2010.06.011_bib20","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mrm.20649","article-title":"How to investigate oxygen supply, uptake, and utilization simultaneously by interleaved NMR imaging and spectroscopy of the skeletal muscle","volume":"54","author":"Carlier","year":"2005","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mrm.1910350109","article-title":"Perfusion changes in human skeletal muscle during reactive hyperemia measured by echo-planar imaging","volume":"35","author":"Toussaint","year":"1996","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/mrm.1910400408","article-title":"Evidence of muscle BOLD effect revealed by simultaneous interleaved gradient-echo NMRI and myoglobin NMRS during leg ischemia","volume":"40","author":"Lebon","year":"1998","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/mrm.20760","article-title":"Influence of vascular filling and perfusion on BOLD contrast during reactive hyperemia in human skeletal muscle","volume":"55","author":"Duteil","year":"2006","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mrm.21319","article-title":"Absolute and relative contributions of BOLD effects to the muscle functional MRI signal intensity time course: effect of exercise intensity","volume":"58","author":"Damon","year":"2007","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib25","first-page":"89","article-title":"Functional magnetic resonance imaging of muscle","volume":"28","author":"Meyer","year":"2000","journal-title":"Exerc Sport Sci Rev"},{"key":"10.1016\/j.nmd.2010.06.011_bib26","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1152\/jappl.2001.91.6.2679","article-title":"Skeletal muscle intracellular PO(2) assessed by myoglobin desaturation: response to graded exercise","volume":"91","author":"Richardson","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nmd.2010.06.011_bib27","doi-asserted-by":"crossref","first-page":"R1441","DOI":"10.1152\/ajpregu.00242.2004","article-title":"Metabolic and vascular support for the role of myoglobin in humans: a multiparametric NMR study","volume":"287","author":"Duteil","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.nmd.2010.06.011_bib28","series-title":"Muscle Biopsy: A Practical Approach","author":"Dubowitz","year":"2007"},{"issue":"Suppl. 1","key":"10.1016\/j.nmd.2010.06.011_bib29","first-page":"92","article-title":"Influence of workload on human calf muscle following dynamic aerobic exercise: BOLD effect, perfusion, oxygenation and energetics assessed by mpf-NMR","volume":"21","author":"Monnet","year":"2008","journal-title":"MAGMA"},{"key":"10.1016\/j.nmd.2010.06.011_bib30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(82)92635-6","article-title":"Clinical use of nuclear magnetic resonance in the investigation of myopathy","volume":"1","author":"Edwards","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2010.06.011_bib31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2214\/ajr.179.4.1790989","article-title":"MR imaging of primary skeletal muscle diseases in children","volume":"179","author":"Chan","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.nmd.2010.06.011_bib32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOR.0b013e3282efdc66","article-title":"Skeletal muscle imaging and inflammatory myopathies","volume":"19","author":"Kuo","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nmd.2010.06.011_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clinph.2005.10.010","article-title":"The use of MRI in the evaluation of myopathy","volume":"117","author":"Lovitt","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2010.06.011_bib34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0720-048X(01)00399-0","article-title":"Hereditary neuromuscular diseases","volume":"40","author":"Ozsarlak","year":"2001","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.nmd.2010.06.011_bib35","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0730-725X(96)00236-6","article-title":"MR quantification of muscle fatty replacement in McArdle\u2019s disease","volume":"14","author":"de Kerviler","year":"1996","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.nmd.2010.06.011_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nmd.2003.08.003","article-title":"Muscle MRI in adult-onset acid maltase deficiency","volume":"14","author":"Pichiecchio","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2010.06.011_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mus.880060204","article-title":"Clinical investigation in Duchenne dystrophy: 2. Determination of the \u201cpower\u201d of therapeutic trials based on the natural history","volume":"6","author":"Brooke","year":"1983","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2010.06.011_bib38","first-page":"348","article-title":"Functional ability and equipment use among patients with neuromuscular disease","volume":"68","author":"Lord","year":"1987","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2010.06.011_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0009-8981(92)90013-G","article-title":"Carbon-13 magnetic resonance in biology and medicine","volume":"206","author":"Seelig","year":"1992","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.nmd.2010.06.011_bib40","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1051\/jcp\/1995921797","article-title":"Diagnostic value of the evaluation of the glycogen content in muscle diseases by carbon 13 nuclear magnetic resonance","volume":"92","author":"Jehenson","year":"1995","journal-title":"J Chim Phys"},{"key":"10.1016\/j.nmd.2010.06.011_bib41","first-page":"1479","article-title":"13C NMR spectroscopy of lipids: a simple method for absolute quantitation","volume":"16","author":"Wary","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1016\/j.nmd.2010.06.011_bib42","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.0.CO;2-6","article-title":"Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease","volume":"22","author":"Tarnopolsky","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2010.06.011_bib43","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archneur.1984.04050210025008","article-title":"Clinical varieties of neuromuscular disease in debrancher deficiency","volume":"41","author":"Cornelio","year":"1984","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2010.06.011_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jnnp.67.3.364","article-title":"Different clinical aspects of debrancher deficiency myopathy","volume":"67","author":"Kiechl","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2010.06.011_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02889849","article-title":"Infantile acid maltase deficiency. I. Muscle fiber destruction after lysosomal rupture","volume":"45","author":"Griffin","year":"1984","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.nmd.2010.06.011_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2010.06.011_bib47","first-page":"41","article-title":"31P NMR spectroscopy of myopathies: clinical application of whole-body MR","volume":"4","author":"Itoh","year":"1986","journal-title":"Radiat Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib48","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1212\/WNL.37.4.663","article-title":"Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis","volume":"37","author":"Duboc","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.06.011_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0925-4439(93)90124-J","article-title":"A 31P and 1H NMR investigation in vitro of normal and abnormal human liver","volume":"1225","author":"Bell","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nmd.2010.06.011_bib50","doi-asserted-by":"crossref","first-page":"7714","DOI":"10.1073\/pnas.79.24.7714","article-title":"31P NMR studies of control of mitochondrial function in phosphofructokinase-deficient human skeletal muscle","volume":"79","author":"Chance","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2010.06.011_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1566524024605761","article-title":"Glycogen and its metabolism","volume":"2","author":"Roach","year":"2002","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.nmd.2010.06.011_bib52","first-page":"167","article-title":"The role of phosphate in muscle glycogen","volume":"4","author":"Lomako","year":"1994","journal-title":"Biofactors"},{"key":"10.1016\/j.nmd.2010.06.011_bib53","doi-asserted-by":"crossref","first-page":"19262","DOI":"10.1073\/pnas.0707952104","article-title":"Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo","volume":"104","author":"Tagliabracci","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2010.06.011_bib54","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/1097-4598(200009)23:9<1316::AID-MUS2>3.0.CO;2-I","article-title":"Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy","volume":"23","author":"Argov","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2010.06.011_bib55","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/(SICI)1097-4598(199606)19:6<764::AID-MUS12>3.0.CO;2-L","article-title":"Impairment of muscle mitochondrial oxidative metabolism in McArdles\u2019s disease","volume":"19","author":"De Stefano","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2010.06.011_bib56","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1152\/jappl.1985.59.6.1991","article-title":"Muscle fatigue in McArdle\u2019s disease studied by 31P-NMR: effect of glucose infusion","volume":"59","author":"Lewis","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nmd.2010.06.011_bib57","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/nbm.1081","article-title":"Muscle blood flow and oxygenation measured by NMR imaging and spectroscopy","volume":"19","author":"Carlier","year":"2006","journal-title":"NMR Biomed"},{"key":"10.1016\/j.nmd.2010.06.011_bib58","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.4076\/1757-1626-2-6891","article-title":"Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report","volume":"2","author":"Ismail","year":"2009","journal-title":"Cases J"},{"key":"10.1016\/j.nmd.2010.06.011_bib59","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/mus.21201","article-title":"Diabetes mellitus associated with glycogen storage disease type III","volume":"39","author":"Spengos","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2010.06.011_bib60","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1464-5491.2000.00378.x","article-title":"Diabetes mellitus secondary to glycogen storage disease type III","volume":"17","author":"Oki","year":"2000","journal-title":"Diabet Med"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610002658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610002658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:58:40Z","timestamp":1760774320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896610002658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0960896610002658"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2010.06.011","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating glycogenosis type III patients with multi-parametric functional NMR imaging and spectroscopy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2010.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}